News
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural hearing loss, with milestone payments exceeding $1.3 billion.
The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from a patient.
19h
Barchart on MSNJim Cramer Says You Should Buy This ‘Strong Buy’ Stock ‘Hand Over Fist’Eli Lilly (LLY) is a leading pharmaceutical company that discovers, develops, manufactures, and markets healthcare products.
The pharmaceutical industry's patience is wearing thin with the Trump administration's pressure. But the administration doesn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results